HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

A new zinc chelator, IPZ-010 ameliorates postoperative ileus.

Abstract
Zinc was discovered to be a novel second messenger in immunoreactive cells. We synthesized a novel free zinc chelator, IPZ-010. Here, we investigated the effects of IPZ-010 in a mouse postoperative ileus model and determined the effects of zinc signal inhibition as a new therapeutic strategy against postoperative ileus. Zinc waves were measured in bone marrow-derived mast cells (BMMCs) loaded with a zinc indicator, Newport green. Degranulation and cytokine expression were measured in BMMCs and bone marrow-derived macrophages (BMDMs). Postoperative ileus model mice were established with intestinal manipulation. Mice were treated with IPZ-010 (30 mg/kg, s.c. or p.o.) 1 h before and 2 h and 4 h after intestinal manipulation. Gastrointestinal transit, inflammatory cell infiltration, and expression of inflammatory mediators were measured. Free zinc waves occurred following antigen stimulation in BMMCs and were blocked by IPZ-010. IPZ-010 inhibited interleukin-6 secretion and degranulation in BMMCs. IPZ-010 inhibited tumor necrosis factormRNA expression in BMMCs stimulated with lipopolysaccharide or adenosine triphosphate, whereas IPZ-010 had no effects on tumor necrosis factormRNA expression in BMDMs stimulated with lipopolysaccharide or adenosine triphosphate. In postoperative ileus model mice, IPZ-010 inhibited leukocyte infiltration and cytokine expression, which ameliorated gastrointestinal transit. Furthermore, ketotifen (1 mg/kg) induced similar effects as IPZ-010. These effects were not amplified by co-administration of IPZ-010 and ketotifen. IPZ-010 inhibited zinc waves, resulting in inhibition of inflammatory responses in activated BMMCs in vitro. Targeting zinc waves in inflammatory cells may be a novel therapeutic strategy for treating postoperative ileus.
AuthorsHitomi Kimura, Yutaka Yoneya, Shoma Mikawa, Noriyuki Kaji, Hiroki Ito, Yasuaki Tsuchida, Hirotsugu Komatsu, Takahisa Murata, Hiroshi Ozaki, Ryota Uchida, Keigo Nishida, Masatoshi Hori
JournalBiomedicine & pharmacotherapy = Biomedecine & pharmacotherapie (Biomed Pharmacother) Vol. 123 Pg. 109773 (Mar 2020) ISSN: 1950-6007 [Electronic] France
PMID31862476 (Publication Type: Journal Article)
CopyrightCopyright © 2019. Published by Elsevier Masson SAS.
Chemical References
  • Anti-Inflammatory Agents
  • Antigens, CD
  • Antigens, Differentiation, Myelomonocytic
  • CD68 antigen, human
  • Chelating Agents
  • Ethylenediamines
  • Inflammation Mediators
  • Lipopolysaccharides
  • RNA, Messenger
  • Adenosine Triphosphate
  • Zinc
  • N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine
  • Ketotifen
Topics
  • Adenosine Triphosphate (pharmacology)
  • Animals
  • Anti-Inflammatory Agents (pharmacology, therapeutic use)
  • Antigens, CD (metabolism)
  • Antigens, Differentiation, Myelomonocytic (metabolism)
  • Chelating Agents (chemistry, pharmacology, therapeutic use)
  • Disease Models, Animal
  • Ethylenediamines (pharmacology, therapeutic use)
  • Gastrointestinal Transit (drug effects)
  • Ileus (drug therapy, pathology, physiopathology)
  • Inflammation Mediators (metabolism)
  • Ketotifen (pharmacology)
  • Lipopolysaccharides (pharmacology)
  • Macrophages (metabolism)
  • Mast Cells (drug effects, metabolism)
  • Mice, Inbred BALB C
  • Mice, Inbred C57BL
  • Neutrophils (metabolism)
  • Postoperative Complications (drug therapy, pathology, physiopathology)
  • RNA, Messenger (genetics, metabolism)
  • Zinc (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: